IVD News and Research

RSS

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

14 Jan 2022

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

The advent of the B.1.1.529 (Omicron) severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variant, detected initially in Botswana and South Africa and now found in over 135 countries as of January 3, 2022, has sparked fears of a new global wave of infections and hospitalizations

3 Jan 2022

How the new In-Vitro Diagnostics Regulations are affecting the life sciences landscape

In this interview, News-Medical talks to Laura Nea, Vice President of Quality and Regulatory Management at Tecan, about the upcoming changes to the regulations surrounding in-vitro diagnostics and how they might affect the life sciences landscape.

From Tecan 23 Nov 2021

The Power of Digitalization in the Life Sciences and Diagnostics Sectors

In this interview, News-Medical talks to Frank Buescher and Wael Yared about the increasing digitalization of the life sciences and diagnostics sectors and the possibilities this entails.

From Tecan 19 Nov 2021

The Connection between High-sensitivity Troponin and Heart Attacks

This interview outlines the connection between high-sensitivity troponin and heart attacks.

From Siemens Healthineers 1 Nov 2021

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

Bio-Rad introduces CFX Opus Dx real-time PCR detection systems for IVD use

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System, real-time PCR detection systems that have been listed with the U.S. Food and Drug Administration for IVD testing and that meet the CE-IVD requirement for IVD use in Europe.

From Bio-Rad Laboratories 25 Oct 2021

EKF Diagnostics to exhibit new STAT-Site WB β-ketone and glucose handheld analyzer at Medica 2021

EKF Diagnostics, the global in vitro diagnostics company, announces that it will be exhibiting live & in person at Medica 2021 (Hall 3 Stand B71) for the first time in mainland Europe in two years.

From EKF Diagnostics 25 Oct 2021

EKF Diagnostics to showcase at Medica 2021 STAT-Site® WB β-ketone and glucose handheld analyzer live & in person

KF Diagnostics, the global in vitro diagnostics company, announces that it will be exhibiting live & in person at Medica 2021 (Hall 3 Stand B71) for the first time in mainland Europe in two years.

21 Oct 2021

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer, bringing a wealth of expertise in molecular-based diagnostics to EKF’s leadership team.

From EKF Diagnostics 1 Oct 2021

Bruker’s molecular phenomics research tools enable new insights into ‘long COVID’ and post-acute metabolic abnormalities

A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase.

From Bruker BioSpin Group 22 Jun 2021

Qvella Appoints Richard Brock as VP of Global Marketing and Signals Start of Commercialization

Industry veteran departs bioMérieux to lead the commercialization of Qvella’s lineup of products starting with FAST-Prep, an automated cartridge-based system for Positive Blood Culture (PBC) processing.

19 May 2021

BioEcho receives CE-IVD mark approval for SARS-CoV-2 RNA extraction kit

BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.

11 May 2021

FIND announces launch of a request for proposals to expand access to COVID-19 testing services

The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a request for proposals (RFP) to accelerate the development, manufacturing, and market availability of accurate, affordable, quality-assured and easy-to-use SARS-CoV-2 self-tests for use in low- and middle-income countries (LMICs).

5 Apr 2021

Huron Digital Pathology Receives CE-IVD Mark for TissueScope iQ Scanner

Huron Digital Pathology has received a CE-IVD mark for its high throughput TissueScope iQ 400 slide whole slide scanner.

From Huron Technologies 10 Mar 2021

Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit

As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor of the Genedrive® 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, genedrive plc (LSE: GDR), is for distribution in the US and throughout Europe.

From Beckman Coulter Life Sciences - Flow Cytometry 23 Feb 2021

New WHO essential diagnostics list expands the suite of tests to promote better health

To address the lack of access to tests and testing services in multiple countries, WHO since 2018 has published a yearly essential diagnostics list (EDL), a basket of recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses.

1 Feb 2021

COVID-19 diagnostic tests remain able to detect all published virus strains

Paris, France and Camberley, UK – 21 December 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that following the detection of a new variant of COVID-19 by the UK’s COVID19 Genomics UK consortium, known as VUI-202012/01, the Company has carried out a detailed analysis of the mutations in this new variant and in all published COVID-19 strains to fully assess the reliability of its existing diagnostic tests.

From AFSBio 25 Jan 2021

Owlstone Medical introduces breath biopsy panel for respiratory diseases

Owlstone Medical, the leader in Breath Biopsy® for applications in disease detection, today introduced the Respiratory Diseases Research Use Only Panel.

From Owlstone Medical Ltd 19 Jan 2021

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020